The clinical study to examine efficacies of BSL5-170327C and BSL5-170327S on healthy skin
Latest Information Update: 30 Oct 2017
At a glance
- Drugs BSL5 170327 (Primary)
- Indications Skin disorders
- Focus Therapeutic Use
- Sponsors Kao Corporation
Most Recent Events
- 27 Oct 2017 Status changed from not yet recruiting to completed.
- 19 May 2017 New trial record